Macrophage IRX3 promotes diet-induced obesity and metabolic inflammation.

Metabolic inflammation is closely linked to obesity, and is implicated in the pathogenesis of metabolic diseases. FTO harbors the strongest genetic association with polygenic obesity, and IRX3 mediates the effects of FTO on body weight. However, in what cells and how IRX3 carries out this control are poorly understood. Here we report that macrophage IRX3 promotes metabolic inflammation to accelerate the development of obesity and type 2 diabetes. Mice with myeloid-specific deletion of Irx3 were protected against diet-induced obesity and metabolic diseases via increasing adaptive thermogenesis. Mechanistically, macrophage IRX3 promoted proinflammatory cytokine transcription and thus repressed adipocyte adrenergic signaling, thereby inhibiting lipolysis and thermogenesis. JNK1/2 phosphorylated IRX3, leading to its dimerization and nuclear translocation for transcription. Further, lipopolysaccharide stimulation stabilized IRX3 by inhibiting its ubiquitination, which amplified the transcriptional capacity of IRX3. Together, our findings identify a new player, macrophage IRX3, in the control of body weight and metabolic inflammation, implicating IRX3 as a therapeutic target. © 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Citation

Jingfei Yao, Dongmei Wu, Chunyan Zhang, Ting Yan, Yiheng Zhao, Hongyu Shen, Kaili Xue, Xun Huang, Zihao Wang, Yifu Qiu. Macrophage IRX3 promotes diet-induced obesity and metabolic inflammation. Nature immunology. 2021 Oct;22(10):1268-1279

Mesh Tags

Substances

PMID: 34556885

search → result